Rallybio Corporation
RLYB · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $42 | $97 | $209 | $307 |
| - Cash | $14 | $24 | $57 | $175 |
| + Debt | $0 | $0 | $1 | $0 |
| Enterprise Value | $28 | $73 | $153 | $131 |
| Revenue | $1 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $1 | $0 | $0 | $0 |
| % Margin | 100% | – | – | – |
| EBITDA | -$60 | -$79 | -$68 | -$45 |
| % Margin | -9,491.4% | – | – | – |
| Net Income | -$58 | -$75 | -$67 | -$47 |
| % Margin | -9,084.1% | – | – | – |
| EPS Diluted | -1.33 | -1.84 | -2.09 | -1.46 |
| % Growth | 27.7% | 12% | -43.2% | – |
| Operating Cash Flow | -$49 | -$60 | -$57 | -$46 |
| Capital Expenditures | $0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$49 | -$60 | -$57 | -$46 |